Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

‘Bodyguard’ Protein Helps Protect Young RNAs

21.09.2015

RNA molecules transmit genetic information as blueprints for proteins and fulfil other essential tasks. For this purpose, they undergo a multi-step process during which they must be protected from premature degradation.

Scientists from the Max Planck Institute of Biochemistry (MPIB) in Martinsried have now identified a new mechanism that stabilizes specific RNA molecules and guides their processing. “The molecular complex associated with the protein NCBP3 we identified is primarily important in cellular stress situations such as virus infections,” says Andreas Pichlmair, group leader at the MPIB. “Our findings may open up new therapeutic approaches in the future.”


The newly identified protein NCBP3 (marked in green) at work in the nucleus of the cell (marked in blue). The dotted lines are showing the shape of the cells.

Picture: Andreas Pichlmair / Copyright: MPI of Biochemistry

RNA molecules with defects are rapidly degraded before they can harm the cell. To prevent nascent, still functionless RNA molecules from being destroyed already during RNA synthesis, they are provided with a molecular “cap” to protect them. The vulnerable end of the RNA molecule is thus masked, causing it to evade the cellular waste disposal mechanism.

A “cap-binding complex” (CBC) binds to this cap, thus stabilizing it. The CBC also fulfils other tasks: It regulates the processing of the RNA molecules, which includes the removal of unneeded regions. An important step for mRNAs, which transmit genetic information, is the export from the nucleus of the cell. mRNAs can only serve as blueprints for proteins if they are outside the nucleus, in the cytoplasm.

Until now, the prevailing scientific consensus was that the CBC consists exclusively of two “nuclear cap-binding proteins” (NCBP1 and 2), which bind in tandem to the cap-bearing end of the relevant RNA. Both NCBPs were considered essential for processes such as mRNA export from the cell nucleus. But as the current study shows, a loss of NCBP2 neither restricts this process nor is it harmful to the cell.

“We were able to identify an additional protein that occurs in conjunction with NCBP1, which we named NCBP3,” says Andreas Pichlmair. This protein is found in most higher organisms and is highly conserved in its structure, that is, it is scarcely varied – which suggests that its function is essential.

The conventional cap with NCBP2 is mainly associated with mRNAs and small RNAs. By contrast, the newly discovered complex only occurs with mRNAs that require intensive further processing. In addition, it is particularly important when the cell is stressed – for example, in virus infections. The researcher hopes this finding will open up new therapeutic approaches. It is also significant that the CBC associated with NCBP3 may possibly play a role in diseases that are due to defective RNA processing.

Further studies will now show whether and in what form NCBP3 is involved in anti-virus protection and in the development of diseases. It is already certain that the biogenesis of RNA molecules and thus one of the central processes of the cell is far more complex than previously assumed and is also controlled by external influences.

Original Publication
A. Gebhardt, M. Habjan, C. Benda, A. Meiler, D. Haas, M. Hein, A. Mann, M. Mann, B. Habermann and A. Pichlmair: NCBP3, a cap-binding protein involved in mRNA biogenesis. Nature Communications, September 18, 2015
DOI: 10.1038/ncomms9192

Contact
Dr. Andreas Pichlmair
Innate Immunity
Max Planck Institute of Biochemistry
Am Klopferspitz 18
82152 Martinsried
e-mail: apichl@biochem.mpg.de
http://www.biochem.mpg.de/pichlmair

Dr. Christiane Menzfeld
Public Relations
Max Planck Institute of Biochemistry
Am Klopferspitz 18
82152 Martinsried
Phone: +49 89 8578-2824
e-mail: pr@biochem.mpg.de
http://www.biochem.mpg.de

Weitere Informationen:

http://www.biochem.mpg.de/news - further press releases of the MPI for biochemistry
http://www.biochem.mpg.de/pichlmaier - website of the research group "Innate Immunity" (Andreas Pichlmair)

Anja Konschak | Max-Planck-Institut für Biochemie

More articles from Life Sciences:

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

nachricht Transforming plant cells from generalists to specialists
07.12.2016 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>